Oppenheimer Holdings Inc.

Location

New York

Founded

1881-02-13

Risk Signals

763 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Security Brokers, Dealers, and Flotation Companies, Offices of Bank Holding Companies, Management Investment Offices, Open-End), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Oppenheimer Holdings Inc.

Live alerts from global media, monitored by Business Radar

Randy Moshtael Of Oppenheimer & Co. Inc. Under Investigation: Investor Alert

2025-02-10 (financialadvisorcomplaints.com)

Randy Moshtael Of Oppenheimer & Co. Inc. Under Investigation: Investor Alert

As a financial analyst and legal expert with over a decade of experience, I have seen my fair share of concerning allegations against financial advisors. The

Read more
INOVIO Announces Public Offering of Common Stock & Warrants to Fuel DNA Medicine Development | INO Stock News

2024-12-12 (stocktitan.net)

INOVIO Announces Public Offering of Common Stock & Warrants to Fuel DNA Medicine Development | INO Stock News

INOVIO Pharmaceuticals plans strategic public offering of common stock and warrants, partnering with major financial firms to advance its DNA medicine portfolio.

Read more
Cue Biopharma Announces Pricing of $12.0 Million Public Offering

2024-09-27 (stocktitan.net)

Cue Biopharma Announces Pricing of $12.0 Million Public Offering

Cue Biopharma announces $12M public offering, pricing shares at $0.50. Includes common stock and warrants. Learn about this biotech's financial move and its potential impact on investors. Closing expected Sept 30, 2024.

Read more
Savara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

2023-07-13 (businesswire.com)

Savara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the pricing of an underwr

Read more
Wag! Announces Closing of Business Combination with CHW Acquisition Corporation | Business Wire

2022-08-09 (businesswire.com)

Wag! Announces Closing of Business Combination with CHW Acquisition Corporation | Business Wire

Wag Labs, Inc. (“Wag!” or the “Company”), an American pet services marketplace company powering a mobile-first technology platform that enables on-dem

Read more
Wag! Announces Closing of Business Combination with CHW Acquisition Corporation | Business Wire

2022-08-09 (businesswire.com)

Wag! Announces Closing of Business Combination with CHW Acquisition Corporation | Business Wire

Wag Labs, Inc. (“Wag!” or the “Company”), an American pet services marketplace company powering a mobile-first technology platform that enables on-dem

Read more
The Law Firm of Morgan & Morgan Launches An Investigation Into Oppenheimer Holdings Inc. Regarding Possible Breaches of Fiduciary Duty - OPY

2015-04-16 (prnewswire.com)

The Law Firm of Morgan & Morgan Launches An Investigation Into Oppenheimer Holdings Inc. Regarding Possible Breaches of Fiduciary Duty - OPY

/PRNewswire/ -- Morgan & Morgan is investigating Oppenheimer Holdings, Inc. ("Oppenheimer" or the "Company") (NYSE: OPY) in connection with possible claims of...

Read more
Oppenheimer Asserts Claim

2013-03-15 (prnewswire.com)

Oppenheimer Asserts Claim

/PRNewswire/ - Oppenheimer Holdings Inc. and several of its affiliates (Oppenheimer) today announced the filing of a breach of contract action against Canadian...

Read more
Oppenheimer fund solicitation challenged in investor lawsuit - InvestmentNews

2012-04-24 (investmentnews.com)

Oppenheimer fund solicitation challenged in investor lawsuit - InvestmentNews

The Oppenheimer Holdings solicitation allegedly overstated the value of holdings in the Global Resource Private Equity Fund, described in a private placement memorandum as a fund of funds intending to invest in natural resource-related companies.

Read more
Agreement Reached for ESSA Pharma to Acquire Realm Therapeutics - ESSA Pharma (NASDAQ:EPIX) -

(benzinga.com)

Agreement Reached for ESSA Pharma to Acquire Realm Therapeutics - ESSA Pharma (NASDAQ:EPIX) -

Acquisition Expected to be Completed by Mid-Year 2019

Read more

Never miss a headline about Oppenheimer Holdings Inc.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages